AMPLIPHI BIOSCIENCES CORPORATION INTERIM CHIEF OPERATING OFFICER AGREEMENTInterim Chief Operating Officer Agreement • April 15th, 2015 • AmpliPhi Biosciences Corp • Biological products, (no disgnostic substances) • Virginia
This Interim Chief Operating Officer Agreement (“Agreement”) is entered into by and between AmpliPhi Biosciences Corporation, a Washington corporation (the “Company”) and Wendy S. Johnson (“Consultant”), on September 18, 2014, and shall be deemed to be effective as of September 1, 2014. The Company desires to retain Consultant as an independent contractor to perform services for the Company on an interim basis, and Consultant is willing to perform such services, on the terms described below. In consideration of the mutual promises contained herein, the parties agree as follows:
AMENDMENT TO INTERIM CHIEF OPERATING OFFICER AGREEMENTInterim Chief Operating Officer Agreement • April 16th, 2015 • AmpliPhi Biosciences Corp • Biological products, (no disgnostic substances)
THIS AMENDMENT TO INTERIM CHIEF OPERATING OFFICER AGREEMENT (this “Amendment”), is made this 15th day of January, 2015 (the “Effective Date”), by and among AmpliPhi Biosciences, a Washington corporation (the “Company”) and Wendy S. Johnson (the “Consultant”).
